Our results indicate a novel function for nuclear Gal-1, in mediating the loss of the tumor-suppressive function of FOXP3 through interaction with the FKH domain and inhibition of the DNA-binding ability of FOXP3 in breast cancer cells. This evidence concerns the gene FOXP3 and breast carcinoma.